Astragaloside IV attenuates angiotensin II-induced inflammatory respon

Introduction

In the world, cardiovascular diseases remain the major causes of morbidity and mortality.1,2 Inflammation, as a significant hallmark of endothelial injury, is recognized to contribute to the development of cardiovascular diseases.3,4 Numerous studies demonstrate that the disruption of endothelial cell homeostasis, a condition defined as endothelial dysfunction, contributes to the pathogenesis of various inflammation-characterized circulatory disorders, including atherosclerosis, hypertension, and ischemia-reperfusion injury.4–6 Currently, endothelial dysfunction is thought to be the critical initiating factor for inflammation and frequently associated with mitochondrial dysfunction.7,8 Mitochondrial reactive oxygen species (ROS) are involved in the…

Source link

Leave a Comment